Mark J. Pino is a Partner in the firm's Intellectual Property Group. He represents clients in a variety of areas including patent counseling and opinions, litigation, due diligence, interferences, and prosecution and reexaminations in pharmaceutical, biochemical, and chemical matters. He has significant experience with ANDA litigations and cases before the International Trade Commission.

His technical background covers subject matter involving small molecules, pharmaceuticals, organic chemistry, cell and biochemical based assays, inorganics, and fluoropolymers. Prior to becoming a patent attorney he worked as a Medicinal Chemist at Agouron Pharmaceuticals, and contributed to the discovery of Viracept®, an anti-HIV inhibitor.

Mark is a co-vice chair of the firm's Patent Prosecution and Counseling section, a member of the Hiring Committee and a member of the Associate Evaluation Committee.